Bloodwork tuned to APOE4. Pods that hold you accountable. Every relevant clinical trial, filtered to you, daily.
Takes 7 minutes · 89% see biomarker improvements in 6 months · 60-day money-back
Phoenix members aren't just managing their APOE4 risk—they're transforming their health trajectories.
“I don’t think I would have made it to 72 with my cognition intact if I hadn’t found out and kept up with what’s best for my genes.”
Swipe to see more
Four systems working together to help you optimize faster, validate what works, and access tomorrow's treatments today
"Never Optimize Alone"
Join 579 APOE4 carriers in a private forum with dedicated spaces for interventions, research, tracking, mental health, and real-world meetups. Plus AI-matched accountability pods (2–4 carriers) every month.
Learn moreJoin 579 APOE4 carriers in a private forum with dedicated spaces for interventions, research, tracking, mental health, and real-world meetups. Plus AI-matched accountability pods (2–4 carriers) every month.
Learn moreThe Phoenix method
Built for APOE4 carriers — not generic wellness. Every protocol is validated against your genotype, your bloodwork, and 579+ peer outcomes.
A 7-minute quiz maps your genetic risk, current biomarkers, and personal priorities into a clear baseline.
Get an APOE4-specific protocol with bloodwork targets, supplement stack, and the experiments most likely to move your numbers.
27 biomarkers tracked over time. Phoenix AI surfaces what's working. 89% of members improve within 6 months.
What you'll track
Standard medicine optimizes for the average. APOE4 carriers need tighter, genotype-specific targets — backed by peer-reviewed research and validated across 579+ members.
Experiments · New
Phoenix AI proposes experiments tied to your goals. Your daily check-ins track them automatically. After 14–30 days you get an honest verdict — with the math to back it.
Phoenix AI: “Confidence is at 78%. Tracking is strong — this looks like it's helping you.”
Recently resolved
Based on your goals, biomarkers, and prior research evidence (graded A–D).
From your daily check-ins. No new logging — the data you already capture does the work.
Bayesian confidence — Strong (75%+), Suggestive, or Needs more data. Math, not vibes.
Your next labs auto-verify biomarker experiments — LDL, HbA1c, ApoB, vitamin D, hs-CRP, and more.
Two women. Same APOE4/4 diagnosis — the highest known genetic risk for Alzheimer's. Both fought back in their early 50s. Both gave it everything. Twenty years later, only one of them still recognized her grandchildren.
She didn't try harder. So what did she know?
Takes 5 minutes · 60-day money-back guarantee
IT DEPENDS
on your
even your PREFERENCES matter
IT DEPENDS
on your
even your PREFERENCES matter
A routine you'll follow every day, for the rest of your life.
Guess wrong, and you don't just lose time.
You lose motivation. And without motivation,
even the best intervention fails.
Track 150+ biomarkers with APOE4-optimized ranges. See trends over time. Know what's working.
AI-matched to your monthly goals. Daily check-ins. 3.2x more consistent than going alone.
All your health data in one place. Wearables, bloodwork, supplements, check-ins — connected and analyzed.
Phoenix Core — All of the Above
$69/mo
$2.27/day · billed annually
UNTIL NOW.
Because every month without tracking is a month of guessing.
Accountability pods
Every month, our AI matches you into a peer pod of 2–4 APOE4 carriers. Daily 90-second check-ins. Shared experiments. Real support from people walking the same road.
This is an example. Phoenix AI matches your pod based on your monthly goals, health data, and journey stage.
Now in the Phoenix app
Most APOE4 carriers find a trial after the cohort is full. Phoenix pulls every relevant study from ClinicalTrials.gov, checks it against your profile, and surfaces the ones you may qualify for, with reasons spelled out.
Population-based cohort study tracking biomarker progression in elderly carriers — designed to detect AD years before clinical onset.
Prevention trial evaluating subcutaneous gantenerumab in cognitively normal APOE4 homozygotes aged 55–75.
Member Perks
$1,600+/year in exclusive partner perks. Hand-picked.
The math of APOE4
An APOE4/4 genotype raises lifetime Alzheimer’s risk roughly 4–5× above baseline. But research shows that aggressive, genotype-specific intervention can bring that number down close to baseline — and the benefit compounds at every age you start.
Lifetime risk by age 85. Source: Genin E et al., Mol Psychiatry 2011.
The lifetime number hides the real urgency.
Alzheimer’s biology starts two decades before symptoms — and APOE4/4 carriers show near-full pathology penetrance by 65. The good news: clinical trials show APOE4 carriers see 2.6× greater cognitive benefit from multidomain intervention than non-carriers. Whether you start at 50 or 70, every year of intervention bends the curve.
Sources: Fortea J et al., Nat Med 2024 · Ngandu T et al., Lancet 2015 (FINGER) · Genin E et al., Mol Psychiatry 2011.
Takes 7 minutes. No credit card required.
Every month without tracking is a month of data you can't get back. Join 579+ APOE4 carriers already tracking 27 biomarkers.
Don't wait for June. The best time to start is today.
Founded by Dr. Kevin Tran, PharmD — APOE 4/4 carrier
32% of our members are healthcare professionals
“I built Phoenix because I needed it. Now we build it together.”
